Cancer therapies lead way as FDA tallies 60 drug approvals in 2021 January 2, 2022 Auto Bot BioPharma, biopharma nl, cancer, Clinical Trials, FDA, Legal, Pharma, Rare diseases, regenerative medicine 0 As in previous years, cancer products topped the list of new FDA-approved therapies in 2021. But the list of drug approvals is notable for other trends, including developments in rare diseases and regenerative medicine.